These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Variations in human metabolism of methaqualone given in therapeutic doses and in overdose cases studied by gas chromatography-mass spectrometry. Bonnichsen R; Dimberg R; Mårde Y; Ryhage R Clin Chim Acta; 1975 Apr; 60(1):67-75. PubMed ID: 1126031 [TBL] [Abstract][Full Text] [Related]
24. A Multifaceted GABAA Receptor Modulator: Functional Properties and Mechanism of Action of the Sedative-Hypnotic and Recreational Drug Methaqualone (Quaalude). Hammer H; Bader BM; Ehnert C; Bundgaard C; Bunch L; Hoestgaard-Jensen K; Schroeder OH; Bastlund JF; Gramowski-Voß A; Jensen AA Mol Pharmacol; 2015 Aug; 88(2):401-20. PubMed ID: 26056160 [TBL] [Abstract][Full Text] [Related]
25. Biotransformation of mecloqualone in man. Synthesis and identification of some major metabolites. Daenens P; van Boven M Arzneimittelforschung; 1974 Feb; 24(2):195-202. PubMed ID: 4406370 [No Abstract] [Full Text] [Related]
26. [Spectrophotometric determination of methaqualone in biologic material]. Kerde C Arzneimittelforschung; 1975 Mar; 25(3):363-5. PubMed ID: 1174032 [TBL] [Abstract][Full Text] [Related]
28. Biochemical studies of drug and steroid metabolism by the liver. Estabrook RW; Remmer H; Hildebrandt A; Cooper DY Masui; 1968 Sep; 17(10):990-7. PubMed ID: 5750969 [No Abstract] [Full Text] [Related]
30. Studies on metabolism of 2-methyl-3-o-tolyl-4(3H)-quinazolinone. I. The estimationof 2-methyl-3-o-toly-4(3H)-quinazolinone in biological materials. AKAGI M; OKETANI Y; TAKADA M Chem Pharm Bull (Tokyo); 1963 Jan; 11():62-7. PubMed ID: 14011479 [No Abstract] [Full Text] [Related]
31. [Development of tolerance to methyl-o-tolyl-quinazolinone in rats]. Zilletti L; Perretti F Riv Ostet Ginecol; 1969 Jan; 24(1):12-7. PubMed ID: 5404733 [No Abstract] [Full Text] [Related]
32. Synthesis and central nervous system activity of quinazolones related to 2-methyl-3-(o-tolyl)-4(3H)-quinazolone (methaqualone). Ager IR; Harrison DR; Kennewell PD; Taylor JB J Med Chem; 1977 Mar; 20(3):379-86. PubMed ID: 845871 [TBL] [Abstract][Full Text] [Related]
33. [Characteristic of the distribution of neurotropic agents in the brain (review of the literature)]. Fateev VA; Titov NS Farmakol Toksikol; 1981; 44(5):630-3. PubMed ID: 6118291 [No Abstract] [Full Text] [Related]
35. [Transplacental transfer of methyl-o-tolyl-quinazolinone in rat and its fetal repercussions]. Perretti F; Zilletti L Riv Ostet Ginecol; 1969 Jan; 24(1):1-11. PubMed ID: 5404735 [No Abstract] [Full Text] [Related]
36. [ELECTROENCEPHALOGRAPHIC STUDY ON METHAQUALONE]. MIYAGISHI K Nihon Yakurigaku Zasshi; 1964 Nov; 60():569-72. PubMed ID: 14280382 [No Abstract] [Full Text] [Related]
37. Preparation of 2-methyl-3-(2-hydroxymethyl)phenyl-4(3H)-quinazalone: a metabolite of methaqualone. Cella JA J Pharm Sci; 1974 Oct; 63(10):1627. PubMed ID: 4436802 [No Abstract] [Full Text] [Related]
38. EFFECT OF METHAQUALONE HYDROCHLORIDE IN PREGNANT RABBITS AND RATS. BOUGH RG; GURD MR; HALL JE; LESSEL B Nature; 1963 Nov; 200():656-7. PubMed ID: 14109942 [No Abstract] [Full Text] [Related]